Assets


SiNON Nano Sciences assets are based on cutting-edge Carbon Nano Particles(CNP) technology, which forms the basis of our innovative products aimed at improving drug delivery systems and therapeutic outcomes.

Versatility: Our CNPs are engineered to conjugate with various compounds, enhancing their functionality and application across different therapeutic areas. 
Targeted Delivery: By conjugating CNPs with molecules like Arginine Peptide, we can achieve precise targeting, reducing side effects and increasing treatment efficacy.
Enhanced Drug Encapsulation: Our CNP-based formulations are designed to encapsulate drug, improving their stability and controlled release.

  • Carbon Nano Particles in SiNON

    Asset Name: CNP Asset Description: Carbon Nano Particle Code: CNP-1001...

  • Carbon Nano Particles with Arginine in SiNON

    Asset Name: CNP-Arg Asset Description: Carbon Nano Particle conjugated with...

  • CNP PTX in SiNON

    Asset Name: CNP-PTX Asset Description: Paclitaxel encapsulated in Carbon Nano...

  • CNP TPT in SiNON

    Asset Name: CNP-TPT Asset Description: Topotecan encapsulated in Carbon Nano...

  • CNP TMZ in SiNON

    Asset Name: CNP-TMZ Asset Description: Temazolomide encapsulated in Carbon Nano...

  • Paclitaxel in SiNON

    Asset Name: CNP-Arg-PTX Asset Description: Paclitaxel encapsulated in Carbon Nano...

  • CNP ARG TPT in SiNON

    Asset Name: CNP-Arg-TPT Asset Description: Topotecam encapsulated in Carbon Nano...

  • CNP Arg TMZ in SiNON

    Asset Name: CNP-Arg-TMZ Asset Description: Temazolomide encapsulated in Carbon Nano...